Karyopharm Therapeutics Inc. (KPTIQ) stock
KPTIQPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Karyopharm Therapeutics statistics
37 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 136.7%
- 10.8%
- Shares Change (QoQ)
- 0.60%
- 0.50%
- Float
- 22M
- 49M
- Shares Held by Insiders
- 3.71%
- 11.7%
- Shares Held by Institutions
- 96.1%
- 56.4%
MarginsIndustry
- Pretax Margin
- -153.3%
- -11.6%
- EBITDA Margin
- -56.2%
- -27.7%
Returns on capitalIndustry
- Return on Assets (ROA)
- -207.9%
- -40.6%
Financial positionIndustry
- Current Ratio
- 0.79
- 3.30
- Quick Ratio
- 0.71
- 2.39
- Interest Coverage
- -1.67
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 6.81%
- 6.82%
- Revenue Growth (3Y CAGR)
- -2.39%
- 2.25%
- Revenue Growth (5Y CAGR)
- 6.21%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 1.36
- 0.40
- Revenue Per Employee
- $643.08K
- $429.29K
- Profits Per Employee
- -$985.70K
- -$689.41K
- Employee Count
- 228
- 74
Income statement (TTM)Industry
- Pretax Income
- -$224.77M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $65.10M
- $17.76M
- Net Cash Per Share
- $2.87
- $0.80
- Equity (Book Value)
- -$330.17M
- $53.89M
- Book Value Per Share
- -$14.56
- $1.50
- Tangible Book Value
- -$330.17M
- $27.13M
- Working Capital
- -$27.86M
- $79.99M
Cash flow (TTM)Industry
Taxes and interestIndustry
- Interest Expense
- $49.32M
- $2.90M
- Income Tax
- -$32.00K
- $73.00K
Scores and fair valueIndustry
- Piotroski F-Score
- 3
- 4
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?